🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07657637
Starting soon Not applicable

Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome

NCT07657637 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-06-30
Last updated
2026-06-18

Condition(s) studied

Shock WaveSubacromial Impingement Syndrome

Investigational drug(s) / intervention(s)

sodium diclofenac radial shock wave phonophoresis plus conventional physical therapyradial shock wave therapy plus conventional physical therapy

sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy: patients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2.4 bars, 10 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle).

radial shock wave therapy plus conventional physical therapy: patients will receive radial shock wave therapy ( 2000 shocks, 2.4 bars, 10 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle).

Study summary

The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:

does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.

Group (B): Patients will receive shock wave plus conventional Physical therapy.

Eligibility

Sex
ALL
Min age
25 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Patients age range between 25-40 years ago. * Shoulder pain between 60- 120° with shoulder elevation (positive painful arch test). * Grade 2 impingement syndrome according to neer classification. Exclusion Criteria: * Shoulder affected bilaterally * Receiving anesthetic or corticosteroid injections within 4 weeks of study enrollment * Surgery or previous fractures of the ipsilateral humeral head of the affected shoulder * Osteoarthritis in the acromioclavicular or glenohumeral joints

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Modern University for Technology and Information, Cairo, , Egypt Cairo Egypt

More MTI University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07657637 on ClinicalTrials.gov ↗ ← All trials in Egypt